Thus, an evaluation of drug resistance in tumor cells of leukemia patients measured as MDR1 mRNA levels has prognostic value for individual hematological disorders, in particular for newly diagnosed patients with AML. This evidence concerns the gene ABCB1 and hematologic disorder.